pamidronate has been researched along with thalidomide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (88.24) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Toussirot, E; Wendling, D | 1 |
| Hussein, MA; Juturi, JV; Lieberman, I | 1 |
| Baran, W; Ciepłuch, H; Hellmann, A | 1 |
| Greipp, PR | 1 |
| Ferraro, G | 1 |
| Davis, JC; Scalapino, KJ | 1 |
| Bazarbachi, A; Daher, R; El-Sabban, ME; Haidar, JH; Nasr, MR | 1 |
| Davis, JC; Huang, F; Maksymowych, W | 1 |
| El Maghraoui, A | 1 |
| Chou, T | 1 |
| Bemardeschi, P; Dentico, P; Fiorentini, G; Giustarini, G; Rossi, S; Turano, E | 1 |
| Attal, M; Avet-Loiseau, H; Benboubker, L; Berthou, C; Bourhis, JH; Caillot, D; Doyen, C; Dumontet, C; Facon, T; Garderet, L; Grobois, B; Harousseau, JL; Hulin, C; Leyvraz, S; Marit, G; Monconduit, M; Moreau, P; Pegourie, B; Renaud, M; Voillat, L; Yakoub Agha, I | 1 |
| McKenna, KE; Morris, TC; Ramadan, KM | 1 |
| Alsayed, Y; Anaissie, E; Barlogie, B; Crowley, J; Epstein, J; Hoering, A; Hollmig, K; Jenkins, B; Kumar, NS; Petty, N; Pineda-Roman, M; Shaughnessy, JD; Srivastava, G; Szymonifka, J; van Rhee, F; Yaccoby, S; Zeldis, JB | 1 |
| Roberge, D; Rotondo, RL; Shustik, C; Skamene, S | 1 |
8 review(s) available for pamidronate and thalidomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic advances in ankylosing spondylitis.
Topics: Cyclooxygenase Inhibitors; Diphosphonates; Humans; Methotrexate; Pamidronate; Spondylitis, Ankylosing; Thalidomide; Tumor Necrosis Factor-alpha | 2001 |
Multiple myeloma: present and future.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Diphosphonates; Humans; Imidazoles; Multiple Myeloma; Oxides; Pamidronate; Thalidomide; Zoledronic Acid | 2002 |
Smoldering, asymptomatic stage 1, and indolent myeloma.
Topics: Alkylating Agents; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Diet Therapy; Diphosphonates; Erythropoietin; Humans; Multiple Myeloma; Neoplasm Staging; Pamidronate; Thalidomide; Treatment Outcome | 2000 |
The treatment of ankylosing spondylitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antirheumatic Agents; Diphosphonates; Humans; Immunosuppressive Agents; Pamidronate; Physical Therapy Modalities; Spondylitis, Ankylosing; Thalidomide; Tumor Necrosis Factor-alpha | 2003 |
New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
Topics: Anti-Inflammatory Agents; Diphosphonates; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Pamidronate; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Thalidomide | 2003 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
[Multiple myeloma--recent advances in diagnosis and treatment].
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Diphosphonates; Dose-Response Relationship, Drug; Hematopoietic Stem Cell Transplantation; Humans; Imidazoles; Multiple Myeloma; Neoplasm Staging; Pamidronate; Protease Inhibitors; Pyrazines; Thalidomide; Zoledronic Acid | 2005 |
4 trial(s) available for pamidronate and thalidomide
| Article | Year |
|---|---|
Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Constipation; Diphosphonates; Disorders of Excessive Somnolence; Dizziness; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Osteolysis; Pain; Pamidronate; Remission Induction; Thalidomide; Treatment Outcome | 2002 |
Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma.
Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Dexamethasone; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Pamidronate; Prognosis; Salvage Therapy; Survival Analysis; Thalidomide; Treatment Outcome; Zoledronic Acid | 2003 |
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Diphosphonates; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Pamidronate; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Thalidomide | 2006 |
Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diphosphonates; Disease Progression; Disease-Free Survival; Humans; Immunosuppressive Agents; Multiple Myeloma; Multivariate Analysis; Pamidronate; Precancerous Conditions; Salvage Therapy; Thalidomide; Time Factors; Treatment Outcome | 2008 |
5 other study(ies) available for pamidronate and thalidomide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Geraldine Ferraro. The fight of her life. Interview by Jo Cavallo.
Topics: Aged; Antineoplastic Agents; Diphosphonates; Female; Humans; Immunosuppressive Agents; Multiple Myeloma; Pamidronate; Politics; Polypharmacy; Research Support as Topic; Survivors; Thalidomide; United States | 2002 |
Signet ring-like light chain myeloma with systemic spread.
Topics: Anemia; Antineoplastic Agents; Bone Marrow Examination; Combined Modality Therapy; Diagnostic Errors; Diphosphonates; Gingival Hemorrhage; Humans; Immunoglobulin Light Chains; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplastic Stem Cells; Pamidronate; Plasma Cells; Primary Myelofibrosis; Radiotherapy, Adjuvant; Splenectomy; Splenic Neoplasms; Thalidomide; Thrombocytopenia; Tomography, X-Ray Computed | 2003 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid | 2006 |
Necrosis following skull base irradiation and stem cell transplant for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cranial Irradiation; Dexamethasone; Diphosphonates; Humans; Male; Middle Aged; Multiple Myeloma; Necrosis; Pamidronate; Skull Base; Skull Base Neoplasms; Stem Cell Transplantation; Thalidomide; Transplantation, Homologous | 2010 |